Background: CMV is a major clinical problem in transplant recipients. Thus, it is important to
use sensitive and specific diagnostic techniques to rapidly and accurately detect CMV …

Methods 30 recipients of LT were screened for the appearance of CMV infection by using
ELISA to test anti-CMV-Ab from serum samples and using immunohistochemistry method to …

OBJECTIVE: To evaluate the clinical usefulness of cytomegalovirus (CMV) antigenemia
assay among liver transplant recipients in Samsung Medical Center. MATERIALS AND …

The most common organ‐specific manifestation of cytomegalovirus (CMV) infection after
liver transplantation is hepatitis. Here we retrospectively describe the detailed virological …

Background: Cytomegalovirus (CMV) is a significant problem in transplantation. The antiviral
treatment is based on the clinical symptoms and the rapid laboratory diagnosis. Although …

Objective. We assessed a new cytomegalovirus (CMV) DNA hybridization assay. We also
compared the assay with other currently used assays to determine its use in the early …

Background Cytomegalovirus (CMV) remains a major cause of morbidity and mortality for
liver transplant recipients. Although the CMV pp65 antigenemia (AG) assay has been widely …

Cytomegalovirus (CMV) is a β-herpesvirus. CMV infections are a common complication
contributing to morbidity and mortality after liver transplantation. Among organ transplant …

Background. Human cytomegalovirus (CMV) is a significant cause of morbidity and mortality
among transplant recipients. Monitoring transplant recipients by CMV IgM serology has …

Background. The early detection of cytomegalovirus (CMV) after liver transplantation may
form the basis of a preemptive strategy for prevention of active CMV disease. Methods. We …